Track the 셀바이오휴먼텍 stock price and the full insider trade history of the company, a publicly traded company based in South Korea. Shares are quoted on KR KR, under the oversight of DART (FSS). Operating in the Food & Beverage sector, 셀바이오휴먼텍 has logged 42 insider filings. Market capitalisation: €49.1bn. The latest transaction was disclosed on 12 June 2026 (Other). Among the most active insiders: 이권선. All data is free.
42
Insider Decl.
0
Thresholds
·
27 ops.
Buy Volume
·
0 ops.
Sell Volume
22Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 5,404 of 26,334 companies
66.5
score / 100
Value
65
Quality
68
FCF yld-10%
Earn yld16%
EV/EBITDA6.3x
ROE17%
Gross mgn37%
Net mgn17%
Debt/EBITDA1.7x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.